You are here

Article Text

Article menu

See original article:

Download PDFPDF

Correction
Correction: Intratumoral administration of STING-activating nanovaccine enhances T cell immunotherapy

http://dx.doi.org/10.1136/jitc-2021-003960corr1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Jiang X, Wang J, Zheng X, et al. Intratumoral administration of STING-activating nanovaccine enhances T cell immunotherapy. J Immunother Cancer 2022;10:e003960. doi:10.1136/jitc-2021-003960

    The author Jian Wang has had the following affiliation added: Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Key Laboratory of Cancer Immunology and Biotherapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, China